Induction and Maintenance Treatment With Upadacitinib Improves HRQoL in Patients With Moderately to Severely Active Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
Inflamm. Bowel Dis. 2023 Sep 01;29(9)1421-1430, J Panés, EV Loftus, PDR Higgins, JO Lindsay, W Zhou, X Yao, D Ilo, C Phillips, J Tran, Y Sanchez Gonzalez, S VermeireFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.